다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Contraception, v.81 no.3, 2010년, pp.185 - 196
Zahradnik, H.P. (Clinic for Endocrinology and Reproductive Medicine, University Hospital Freiburg, 79106 Freiburg, Germany) , Hanjalic-Beck, A. , Groth, K.
AI-Helper
Background: This article is a comprehensive overview of dysmenorrhea and a systematic review of the available literature on the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal contraceptives for the therapy and management of dysmenorrhea. Study Design: A comprehensive search of the...
Cameron 410 1999 Dewhurst's textbook of obstetrics and gynaecology for postgraduates Menstrual disorders
National Library for Health
Rees 1 2003 Women's health Menstrual problems
Clin Obstet Gynecol Dawood 33 168 1990 10.1097/00003081-199003000-00023 Dysmenorrhea
Lumsden 421 1997 Gynaecology Menstruation and menstrual abnormality
J Am Board Fam Pract Nasir 17 Suppl S43 2004 10.3122/jabfm.17.suppl_1.S43 Management of pelvic pain from dysmenorrhea or endometriosis
J Adolesc Health Hillen 25 40 1999 10.1016/S1054-139X(98)00147-5 Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment
Obstet Gynecol Clin North Am Smith 20 753 1993 10.1016/S0889-8545(21)00391-0 Cyclic pelvic pain and dysmenorrhea
Am J Obstet Gynecol Andersch 144 655 1982 10.1016/0002-9378(82)90433-1 An epidemiologic study of young women with dysmenorrhea
Arch Pediatr Adolesc Med Banikarim 154 1226 2000 10.1001/archpedi.154.12.1226 Prevalence and impact of dysmenorrhea on Hispanic female adolescents
Arch Pediatr Adolesc Med Campbell 151 905 1997 10.1001/archpedi.1997.02170460043007 Use of medication by adolescents for the management of menstrual discomfort
Br J Obstet Gynaecol Harlow 103 1134 1996 10.1111/j.1471-0528.1996.tb09597.x A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women
Pediatrics Klein 68 661 1981 10.1542/peds.68.5.661 Epidemiology of adolescent dysmenorrhea
Am J Obstet Gynecol Robinson 166 578 1992 10.1016/0002-9378(92)91676-2 Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic
Arch Gynecol Svanberg 230 173 1981 10.1007/BF02111800 The incidence of primary dysmenorrhea in teenagers
J Adolesc Health Care Wilson 10 317 1989 10.1016/0197-0070(89)90065-X A survey of adolescent dysmenorrhea and premenstrual symptom frequency. A model program for prevention, detection, and treatment
J Obstet Gynaecol Can Burnett 27 765 2005 10.1016/S1701-2163(16)30728-9 Prevalence of primary dysmenorrhea in Canada
Int J Gynaecol Obstet Ohde 100 13 2008 10.1016/j.ijgo.2007.06.039 Dysmenorrhea among Japanese women
Br J Obstet Gynaecol Sundell 97 588 1990 10.1111/j.1471-0528.1990.tb02545.x Factors influencing the prevalence and severity of dysmenorrhoea in young women
Br J Obstet Gynaecol Lumsden 90 1135 1983 10.1111/j.1471-0528.1983.tb06460.x Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2 alpha
Am J Obstet Gynecol Lundstrom 130 640 1978 10.1016/0002-9378(78)90320-4 Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women
Prostaglandins Powell 29 273 1985 10.1016/0090-6980(85)90208-4 Menstrual-PGF2 alpha, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea
Acta Obstet Gynecol Scand Stromberg 63 533 1984 10.3109/00016348409156715 Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea
Am J Obstet Gynecol Ylikorkala 130 833 1978 10.1016/0002-9378(78)90019-4 New concepts in dysmenorrhea
Z Geburtshilfe Perinatol Czekanowski 177 202 1973 Influence of prostaglandin F2-alpha on the contractility of the nonpregnant human uterus in vitro
Geburtshilfe Frauenheilkd Zahradnik 37 493 1977 Prostaglandin F2alpha- and 15-methyl-prostaglandin F2alpha-application for the treatment of severe uterine bleedings (author's transl)
Dtsch Med Wochenschr Zahradnik 103 1270 1978 10.1055/s-0028-1129245 New aspects in the pathogenesis and therapy of dysmenorrhea: prostoglandin F2 alpha level in the menstrual blood
Dtsch Med Wochenschr Zahradnik 103 1270 1978 10.1055/s-0028-1129245 The effect of progesterone uterine therapeutic system on dysmenorrhoea: prostaglandin F2alpha levels in menstrual blood (author's transl)
JAMA Miller 95 1796 1930 10.1001/jama.1930.02720240006003 Additional light on dysmenorrhea problem
Gynäkologe Zahradnik 33 225 2000 10.1007/s001290050539 Zyklusabhängige Befindlichkeitsstörungen der Frau
Biomed Pharmacother Simopoulos 56 365 2002 10.1016/S0753-3322(02)00253-6 The importance of the ratio of omega-6/omega-3 essential fatty acids
Science Frisch 169 397 1970 10.1126/science.169.3943.397 Height and weight at menarche and a hypothesis of critical body weights and adolescent events
Eur J Endocrinol Bau 160 107 2009 10.1530/EJE-08-0594 Is there a further acceleration in the age at onset of menarche? A cross-sectional study in 1840 school children focusing on age and bodyweight at the onset of menarche
Am J Hum Biol Danubio 16 470 2004 10.1002/ajhb.20028 Age at menarche and age of onset of pubertal characteristics in 6-14-year-old girls from the Province of L'Aquila (Abruzzo, Italy)
Pediatrics Rosenfield 123 84 2009 10.1542/peds.2008-0146 Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index
Ethn Dis Wattigney 9 181 1999 Secular trend of earlier onset of menarche with increasing obesity in black and white girls: the Bogalusa Heart Study
Obes Surg Sinha 19 113 2009 10.1007/s11695-008-9650-4 A review of adolescent obesity: prevalence, etiology, and treatment
Psychosom Med Moos 30 853 1968 10.1097/00006842-196811000-00006 The development of a menstrual distress questionnaire
Pain Melzack 1 277 1975 10.1016/0304-3959(75)90044-5 The McGill Pain Questionnaire: major properties and scoring methods
Annu Rev Pharmacol Toxicol Chan 23 131 1983 10.1146/annurev.pa.23.040183.001023 Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea
Obstet Gynecol Chan 61 285 1983 Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea
Drugs Dawood 22 42 1981 10.2165/00003495-198122010-00003 Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations
Am J Med Dawood 77 87 1984 10.1016/S0002-9343(84)80025-X Ibuprofen and dysmenorrhea
Am J Med Dawood 84 23 1988 10.1016/0002-9343(88)90473-1 Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea
Acta Obstet Gynecol Scand Suppl Guttadauria 138 11 1986 10.3109/00016348509157060 The clinical pharmacology of piroxicam
Eur J Obstet Gynecol Reprod Biol Kauppila 22 359 1986 10.1016/0028-2243(86)90126-7 Tiaprofenic acid in the treatment of primary dysmenorrhoea
Acta Obstet Gynecol Scand Milsom 67 711 1988 10.3109/00016349809004294 The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea
Am J Obstet Gynecol Owen 148 96 1984 10.1016/S0002-9378(84)80039-3 Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed
Am J Med Pasquale 84 30 1988 10.1016/0002-9343(88)90474-3 A double-blind, placebo-controlled study comparing three single-dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrhea
J Clin Pharmacol Pulkkinen 27 65 1987 10.1177/009127008702700110 Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide
Eicosanoids Nigam 4 137 1991 Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea
Am J Obstet Gynecol Buhimschi 172 1577 1995 10.1016/0002-9378(95)90500-6 Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy
Am J Obstet Gynecol Izumi 169 1327 1993 10.1016/0002-9378(93)90301-X Gestational changes in l-arginine-induced relaxation of pregnant rat and human myometrial smooth muscle
J Int Med Res 25 41 1997 10.1177/030006059702500106 Transdermal nitroglycerine in the management of pain associated with primary dysmenorrhoea: a multinational pilot study
Int J Gynaecol Obstet Moya 69 113 2000 10.1016/S0020-7292(00)00185-5 Transdermal glyceryl trinitrate in the management of primary dysmenorrhea
BMJ Pittrof 312 884 1996 10.1136/bmj.312.7035.884 Crossover study of glyceryl trinitrate patches for controlling pain in women with severe dysmenorrhoea
N Z Med J Pullon 101 52 1988 Prevalence of dysmenorrhoea in Wellington women
Med Hypotheses Backon 28 213 1989 10.1016/0306-9877(89)90054-6 Negative correlation of cigarette smoking and dysmenorrhea: reduced prostaglandin synthesis due to beta-endorphin, nicotine, or acrolein antagonism
Ann Epidemiol Li 17 882 2007 10.1016/j.annepidem.2007.05.010 CYP1A1 gene polymorphisms in modifying the association between passive smoking and primary dysmenorrhea
Epidemiology Wu 11 648 2000 10.1097/00001648-200011000-00006 Metabolic gene polymorphisms and risk of dysmenorrhea
Reprod Toxicol Liu 24 114 2007 10.1016/j.reprotox.2007.04.069 Passive smoking, Cyp1A1 gene polymorphism and dysmenorrhea
J Biosoc Sci Montero 28 315 1996 10.1017/S0021932000022380 Influence of body mass index and slimming habits on menstrual pain and cycle irregularity
Health Psychol Alonso 20 411 2001 10.1037/0278-6133.20.6.411 Disruptions of social relationships accentuate the association between emotional distress and menstrual pain in young women
Occup Environ Med Wang 61 1021 2004 10.1136/oem.2003.012302 Stress and dysmenorrhoea: a population based prospective study
Am Fam Physician Coco 60 489 1999 Primary dysmenorrhea
J Pediatr Adolesc Gynecol Davis 14 3 2001 10.1016/S1083-3188(00)00076-0 Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives
Pain Giamberardino 71 187 1997 10.1016/S0304-3959(97)03362-9 Pain threshold variations in somatic wall tissues as a function of menstrual cycle, segmental site and tissue depth in non-dysmenorrheic women, dysmenorrheic women and men
Am J Physiol Baker 277 E1013 1999 High nocturnal body temperatures and disturbed sleep in women with primary dysmenorrhea
Baranowski 2007 Urogenital pain in clinical practice
2008 Monthly Index of Medical Specialities
Cochrane Database Syst Rev Marjoribanks CD001751 2003 Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea
Ther Umsch Oberholzer 50 13 1993 Incidence of drug side effects by symptoms and syndromes. From the experiences of the Comprehensive Hospital Drug Monitoring and the Swiss Drug Side Effect Center. As an example: allergic and pseudo-allergic reactions with mild analgesics and NSAID
J Womens Health (Larchmt) Daniels 17 423 2008 10.1089/jwh.2007.0416 Efficacy and tolerability of lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials
Cochrane Database Syst Rev Gallo CD003989 2008 20 microg versus >20 microg estrogen combined oral contraceptives for contraception
Contraception Zahradnik 57 103 1998 10.1016/S0010-7824(98)00008-0 Efficacy and safety of the new antiandrogenic oral contraceptive Belara
Contraception O'Connell 75 299 2007 10.1016/j.contraception.2006.09.008 Oral contraceptives: side effects and depression in adolescent girls
Cochrane Database Syst Rev Proctor CD002119 2001 Spinal manipulation for primary and secondary dysmenorrhoea
Cochrane Database Syst Rev Proctor CD002124 2001 Herbal and dietary therapies for primary and secondary dysmenorrhoea
Cochrane Database Syst Rev Proctor CD002123 2002 Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea
Obstet Gynecol Davis 106 97 2005 10.1097/01.AOG.0000165826.03915.65 Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial
Contraception Winkler 69 469 2004 10.1016/j.contraception.2003.12.017 Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol
Eur J Contracept Reprod Health Care Ahrendt 12 354 2007 10.1080/13625180701536771 The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: results from two studies on oestrogen-related symptoms and dysmenorrhoea
J Pediatr Adolesc Gynecol Harel 18 85 2005 10.1016/j.jpag.2004.11.016 Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra
Hum Reprod Kido 22 2066 2007 10.1093/humrep/dem122 The effect of oral contraceptives on uterine contractility and menstrual pain: an assessment with cine MR imaging
J Obstet Gynaecol Res Matsumoto 33 529 2007 10.1111/j.1447-0756.2007.00581.x Impact of use of combined oral contraceptive pill on the quality of life of Japanese women
Contraception Sabatini 76 342 2007 10.1016/j.contraception.2007.07.002 Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents
Contraception Schramm 76 84 2007 10.1016/j.contraception.2007.03.014 Switching hormonal contraceptives to a chlormadinone acetate-containing oral contraceptive. The Contraceptive Switch Study
Int J Clin Pract Bitner 58 340 2004 10.1111/j.1368-5031.2004.00179.x Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea
Clin J Pain Chantler 24 39 2008 10.1097/AJP.0b013e318156dafc The effect of three cyclo-oxygenase inhibitors on intensity of primary dysmenorrheic pain
J Gen Intern Med Daniels 20 62 2005 10.1111/j.1525-1497.2004.30052.x Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen
Prostaglandins Other Lipid Mediat Dawood 83 146 2007 10.1016/j.prostaglandins.2006.10.009 Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea
Am J Obstet Gynecol Dawood 196 35.e1 2007 10.1016/j.ajog.2006.06.091 Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2alpha in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea
Acta Obstet Gynecol Scand de Mello 83 667 2004 10.1111/j.0001-6349.2004.00433.x Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea
J Ethnopharmacol Doubova 110 305 2007 10.1016/j.jep.2006.09.033 Effect of a Psidii guajavae folium extract in the treatment of primary dysmenorrhea: a randomized clinical trial
Eur J Obstet Gynecol Reprod Biol Letzel 129 162 2006 10.1016/j.ejogrb.2006.01.004 The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea
East Mediterr Health J Modaress Nejad 12 423 2006 Comparison of the effectiveness of fennel and mefenamic acid on pain intensity in dysmenorrhoea
BMC Womens Health Edwards 4 5 2004 10.1186/1472-6874-4-5 Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
Cochrane Database Syst Rev Proctor CD002120 2001 Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea
Br J Obstet Gynaecol Zhang 105 780 1998 10.1111/j.1471-0528.1998.tb10210.x Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review
Am Fam Physician French 71 285 2005 Dysmenorrhea
Clin Gastroenterol Hepatol Graham 3 55 2005 10.1016/S1542-3565(04)00603-2 Visible small-intestinal mucosal injury in chronic NSAID users
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.